Chennai meenakshi multispeciality Hospital Limited has submitted its quarterly compliance certificate to regulatory authorities, confirming adherence to SEBI depositories regulations for the quarter ended March 31, 2026. The certificate was filed on April 13, 2026, addressing compliance requirements under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Confirmation

The hospital filed the mandatory certificate with both Central Depository Services India Ltd. and National Securities Depository Ltd., confirming proper handling of dematerialization processes during Q4 FY26. Company Secretary and Compliance Officer M.S. Anantha Lakshmi signed the certificate, ensuring regulatory compliance.

Dematerialization Process Verification

The certificate confirms that all securities received for dematerialization during the quarter were processed according to regulatory requirements. Cameo Corporate Services Limited, serving as the company's Registrar and Share Transfer Agent, provided confirmation of proper verification procedures.

Key compliance aspects covered include:

• Securities received for dematerialization were mutilated and cancelled after due verification
• Depository names were substituted in company records as registered owners
• All processes completed within stipulated time limits under SEBI regulations
• Dematerialized securities remain listed on BSE Limited where earlier issued securities are listed

Registrar Confirmation

Cameo Corporate Services Limited issued a separate confirmation letter dated April 1, 2026, verifying compliance with dematerialization requirements. The registrar confirmed that securities received from depository participants during Q4 FY26 were properly accepted or rejected to depositories within regulatory timeframes.

Corporate Information

The hospital operates under CIN L85110TN1990PLC019545 and maintains its registered office at Old No.149, New No. 70, Luz Church Road, Mylapore, Chennai. The facility holds ISO 9001:2008 and ISO 14001:2004 certifications, reflecting its commitment to quality and environmental management standards.

This quarterly filing demonstrates the hospital's ongoing commitment to regulatory compliance and transparent corporate governance practices in accordance with SEBI requirements for listed entities.

Chennai meenakshi multispeciality Hospital Limited has announced the reconstitution of its key board committees following the resignation of an independent director. The company informed BSE Limited through a regulatory filing dated April 11, 2026, regarding the restructuring of three critical committees under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Background of Committee Reconstitution

The board restructuring follows the resignation of Mr. Kandheri Munaswamy Mohandass (DIN: 00707839) as an Independent Director, which was initially communicated to the exchange on March 17, 2026. The Board of Directors approved the reconstitution through a Circular Resolution passed on April 10, 2026, ensuring compliance with corporate governance requirements.

Audit Committee Composition

The reconstituted Audit Committee comprises three members with Mr. K. Meyyanathan appointed as Chairman. The committee structure ensures appropriate oversight of financial reporting and audit functions.

Nomination and Remuneration Committee Structure

The Nomination and Remuneration Committee has been reconstituted with Mrs. Shama Dhilip as the new Chairman, supported by two other members to oversee compensation and nomination matters.

Stakeholders Relationship Committee Formation

The Stakeholders Relationship Committee has been established with Mr. N. Rajkumar as Chairman, focusing on addressing stakeholder grievances and maintaining investor relations.

The communication was signed by M.S. Anantha Lakshmi, Company Secretary and Compliance Officer, confirming the formal approval and implementation of these committee changes. The reconstitution ensures the hospital maintains proper corporate governance structures while continuing its healthcare operations.